Market, economic implications amid latest virus news

--  |   20/03/2020 Text size  Decrease  Increase   |  
email_fwd
<p><strong>Christine Benz:&nbsp;</strong>Hi, I'm Christine Benz from Morningstar.</p> <p>News about the spread of the coronavirus is changing quickly and, with it, the implications for the economy and the market. Joining me to share some perspectives on these issues are Karen Andersen&mdash;she's a healthcare strategist for Morningstar&mdash;and Preston Caldwell. He's an equity analyst for Morningstar who covers the energy sector.</p> <p>Karen, let's start with you. You've been keeping tabs on the spread of the virus and whether these social-distancing efforts have been working. Can you give us an update?</p> <p><strong>Karen Andersen:&nbsp;</strong>Yeah, sure. Thanks Christine. So yes, we're here one week after publishing our initial coronavirus analysis, four days after our town hall where we talked about the report and health and economic implications. And I have to say, I do at this point&mdash;you know, this is a crazy situation. I understand the panic, you know, as a country, as a planet, we have taken several aggressive steps to control the spread of the coronavirus just in the past few days.</p> <p>And it's probably fair to say that this is uncharted territory for pretty much all of us. And Chicago is really a great example. Last Thursday, I talked about how important the social-distancing steps were. I mentioned conferences being canceled, large gatherings, the potential for working from home. But since that time, many of us who can work from home are now doing so. And Chicago has opted to close schools for March, as well as starting today&mdash;the end of day&mdash;bars and dine-in restaurant service. Countries like France, Spain, are taking similar actions as coronavirus cases in the U.S. and Europe are rising. Also, we've seen some private businesses like Apple are closing their doors. But I guess I'd say overall this is exactly what we need to do, and the fact that this is happening at a rapid pace is encouraging.</p> <p><strong>Benz:&nbsp;</strong>Let's talk about other mitigation efforts. You keep tabs on the healthcare sector. I think we've all been watching that space eagerly, hoping there will be some breakthroughs. Any news on that front in terms of drug development, vaccines, testing, and so forth?</p> <p><strong>Andersen:&nbsp;</strong>We did write a note and quick update on Friday with a little bit of information that we've got on Gilead's leading drug to treat coronavirus, called remdesivir. We are still waiting for the key phase 3 data readout that's going to be coming either later this month or in April. That hasn't changed, but the&nbsp;<em>Wall Street Journal</em>&nbsp;did report on the status of 14 Americans from the Diamond Princess cruise line, who were treated in Japan. These were critically ill patients with an average age around 75 who appear to be doing well two weeks after initiating this 10-day treatment regimen.</p> <p>More than half of them have recovered and there have been no deaths, which&mdash;for reference, you know, the data we have that was published in the Journal of the American Medical Association, from the largest data set we have in China, shows a death rate of about 49% for those who become critically ill. So the fact that these patients are doing fairly well, who had become so sick, I think that is positive news for the potential efficacy of Gilead's drug.</p> <p>Also, Sanofi and Regeneron have announced that they've kind of detailed the study that they'll be performing for their arthritis drug Kevzara, as a coronavirus treatment. So I guess I'd say overall, you know with the mitigation efforts, we're rapidly changing our behavior. We are seeing steady improvements in diagnostic testing and the number of potential treatments that are likely to benefit patients in the long run.</p> <p>But you know, these efforts are just beginning and there's a little bit of a lag here. We're probably gonna see&mdash;I'd say over the next week or two&mdash;an increase in diagnosis. As we get more people tested, we're going to see a lag, and the time for people who maybe were infected, were exposed, before these social-mitigation efforts went into place. So I guess I would just prepare people over the next week or two. This is probably going to get worse before it gets better.</p> <p><strong>Benz:&nbsp;</strong>Okay. Preston, let's turn to you. You and Karen released a report last week where you indicated that the long-term economic impact you thought at the time would be modest. Is that still your view?</p> <p><strong>Preston Caldwell</strong>: Our view is still that in the long run, the economic impact from all of this will be modest. Given that, even with the further slide in equities that we've seen, we still think these equity markets are overreacting. We don't think they're responding to a real long-run threat. Of course, still in the short run we emphasize there could be a significant impact. And in fact, based on a tweaking of our probabilities, based on an emerging assessment of the virus, we have slightly adjusted our economic impact numbers. We thought originally there would be a 1.5% hit to 2020 GDP and now we've bumped that up to 2%. But of course, these probabilities are, you know, fluctuating almost on a daily basis, so take that with a grain of salt. But the key number is that still our long-term impact is minimal, currently at 0.3%. Given that, we don't think that the fall in equities that we've seen so far is warranted.&nbsp;</p> <p>On the economic side there really hasn't been much in terms of new developments outside of what we've conceived. Again, as Karen mentioned, the mitigation efforts that we've seen, obviously they will have some short-term economic impact, but insofar as they help contain the virus, that's really a positive in terms of long-run economic impact. What we really want to avoid is closing factories and logistics supply chains to the greatest extent possible. So, you know, if we can keep as much of the core of the economy running, even while we have a targeted focus on closing schools, large events, etc., that's really a best-case scenario for the economy, especially in the short run.</p> <p>Again, given all that our overall view remains in place, a minimal long-run impact and we think it's an overreaction that we've seen in the equity markets.</p> <p><strong>Benz:&nbsp;</strong>So you cover the energy sector for us. Can you briefly touch on what's been going on there in terms of oil prices and so forth?</p> <p><strong>Caldwell:</strong>&nbsp;So really not much has changed since Thursday when I talked and you know, the big events were or earlier in the week when, when OPEC-plus met and failed to come to a production agreement. And so again, the story there generally remains the same. OPEC-plus, which is OPEC in addition to Russia, is not going to be cutting production. And as a result of the abrogated agreement, they're going to be increasing their production substantially likely through the end of this year. That's gonna cause oil markets to go into oversupply and causes a collapse in oil prices that we've seen, and this is something we think will work itself out&mdash;perhaps sooner, perhaps later. But eventually we will have to see a rebound in oil prices because the marginal supplier of oil globally is US shale, which has a breakeven cost $55 per barrel in our view. Therefore, if we don't see a return to that oil price, then we'll see a collapse in US shale production, which will build the year after year and eventually compel, a rebalancing of global oil supply and demand.&nbsp;</p> <p>So, very troubled in the near run and we eventually expect a return to higher prices. But the duration of the low prices is going to be long enough to really hit energy equities hard. So we've definitely continued to update our views there and we've brought many of our energy equity fair values down over the last week.</p> <p><strong>Benz:&nbsp;</strong>Thank you Preston and Karen for taking time to share your perspective. We'll be checking back with you regularly as new developments unfold.&nbsp;</p> <p><strong>Andersen:</strong>&nbsp;Thank you.&nbsp;</p> <p><strong>Caldwell:&nbsp;</strong>Thank you.</p> <p><strong>Benz:</strong>&nbsp;Thank you for watching. I'm Christine Benz for Morningstar.</p> <p><em>See our full coverage: <img src="http://im.morningstar.com/im/premIcon.gif" alt="" />&nbsp;<a href="cmsgo+article:/#200460" target="_blank">Coronavirus: A guide for Aussie investors</a></em></p>

Video Archive...

Hunker down but the turn isn't far away: Schroders' Simon Doyle
24/06/2022  "I think over the next sort of, three, six, nine months, we're going to see some pretty good opportunities emerge, and I think investors who are well prepared will be able to take advantage of that."
Miners not yet cheap: Morningstar explains the iron ore rout
23/06/2022  Policy will continue to fuel short-term price movements but the long-term fundamentals for Australia's biggest export look shaky.
Anton Tagliaferro on companies to weather the market storm
17/06/2022  The founder of Investors Mutual is cool on Australia's banking giants.
Why are banks selling off as rates rise? Morningstar explains
15/06/2022  Faster interest rate hikes from the Reserve Bank have markets worried about bad debts, says Morningstar banking analyst Nathan Zaia.
"Real chance we've broken the system as it was": Platinum backs regime change
14/06/2022  Highly likely investors are on the cusp of an era of permanently higher rates that should favour "real-world companies", says Andrew Clifford, co-chief investment officer at Platinum Asset Management.
"Get defensive": Warnes on where and when to put cash to work
14/06/2022  Build cash and prepare for opportunistic nibbles at companies such as Aurizon, Wesfarmers and James Hardie, says Morningstar's head of equity research.
"I'm still nervous": Peter Warnes on the outlook for equities
10/06/2022  We haven't seen the bottom of the bear market yet, says Morningstar's head of equity research.
From nosebleed to reason: US tech valuations looking attractive
01/06/2022  Earnings growth remains market leading for wide moat stocks like Alphabet, Meta Platforms and Amazon.
Will the election dampen the Australian resource sector?
30/05/2022  Labor looks set to proceed incrementally and existing producers such as Whitehaven Coal could even benefit should more radical policy be proposed.
'We don't learn': Morningstar sits with King Nudge Richard Thaler
25/05/2022  The Nobel prize winner who cameo'd alongside Selena Gomez in Hollywood hit The Big Short  discusses the latest developments in behavioural economics.
Why are Coles, Woolworths and JB Hi-Fi tanking? Morningstar explains
19/05/2022  Local investors were spooked after US retail giants Target and Walmart plummeted overnight as rising prices hit margins and inventory.
Dan Kemp's best tip for successful long-term investing: Beware market narratives
19/05/2022  On his recent visit to Australia, Morningstar's global chief investment officer Dan Kemp talks investing narratives, confronting the growing list of reasons to be concerned about markets and sustainable investing.
What's driving the latest big drop in US stocks?
19/05/2022  Worries about inflation’s toll on earnings sparks Wednesday’s 4% plunge, but stocks are now far undervalued.
Value strikes back: How to manage style in your portfolio
18/05/2022  One of the big themes of the year has been the value comeback. What is behind this resurgence after a pretty dismal period, and should your portfolio be tilting in its direction?
Is it time to recession-proof your portfolio?
11/05/2022  Here's what investors who are worried about a recession should consider today.
Morningstar Best Ideas List: An undervalued play in telecom
11/05/2022  Morningstar analysts have identified TPG telecom as the most undervalued telecom stocks in the ASX 200 detailing multiple catalysts for earnings recovery and growth.
Bill Browder: A scared Putin will only escalate the conflict
29/04/2022  Exclusive: Hermitage Capital Management CEO Bill Browder talks Putin, Russia, and the next six months for Ukraine
5 risks facing the US market right now
28/04/2022  Inflation, rising interest rates, geopolitical risks, and other things to keep your eye on.
Buffett and Berkshire in 2022
27/04/2022  Morningstar's analyst talks about the Buffett's recent deals, what the stock is worth, and whether Berkshire will pay a dividend any time soon.
Fair value upgrades on the table: Morningstar resources update
31/03/2022  Supply disruptions following Russia's invasion of Ukraine are forcing analysts to consider the possibility elevated prices persist.
Bank outperformance speaks to positive trajectory: Morningstar
30/03/2022  Rising interest rates, strong economic growth and cheaper valuations are driving banking stocks ahead of the broader market.
Stock vs stock: Netflix and Disney
28/03/2022  Where are entertainment and streaming services headed?
Morningstar Best Ideas List: WiseTech looks cheap after tech selloff
24/03/2022  Problems in global supply chains are an opportunity for WiseTech as its logistics company customers move to replace old software.
First fires, then floods: How listed insurers are weathering extreme events
23/03/2022  Markets focused on floods and bushfires are missing how insurers are cutting costs, doing more digitally and are looking down the barrel of a lift in investment income.
Don't get 'whipsawed' by false promises of peace in Europe
17/03/2022  Morningstar Investment Management's global CIO Dan Kemp explains why well-intentioned investors desperate for peace in Europe are making dangerous market calls
Morningstar Best Ideas List: Kogan to hold own in faceoff with Amazon
15/03/2022  Knowledge of the local market, strong branding and a growing subscription service should see the undervalued retailer retain market share in the rapidly growing online sales category, says Roy Van Keulen.
"There's been a big rotation in markets": Value surges as growth stumbles
08/03/2022  Higher inflation, rising interest rates and booming commodity markets are driving a major rotation away from the post-pandemic winners, says Tim Murphy, Morningstar director of manager selection.
Afterpay's rivals set for battle with rates and regulators
03/03/2022  Regulators are likely to be less lenient now the buy-now-pay-later sector is part of the fabric of Australian payments.
Industry champions on the cheap: Emerging markets at the Morningstar Investment Conference
23/02/2022  Strong commodity prices, cheap valuations and a head start on interest rate hikes means emerging markets are set for strength, says Dr. Joseph Lai of Ox Capital.
The Russia crisis is heating up, but you need to stay cool
23/02/2022  A belligerent speech from a president signalled the start of the latest phase of Russian agression last night, causing markets to wobble and investors to wonder.
Peter Warnes on FAANGs, investing in Asia and bond market smoke signals
15/02/2022  In an extended interview, Morningstar's Peter Warnes discusses the bear market in US technology stocks, interest rates and growth and his approach to investing outside the US and Australia.
Weighing up Magellan Financial Group after Douglass surprise exit
13/02/2022  Morningstar equity analyst Shaun Ler explains why he see valuation upside high for MFG even as shares lose steam.
Year of the Tiger: What's next for Chinese stocks
31/01/2022  The Chinese lunar year is almost over, and what a ride it's been. Morningstar speaks to JPMorgan Asset Management strategist Mike Bell about what's ahead. 
What to do (and not do) in a volatile market
23/01/2022  Christine Benz discusses how investors should handle the turmoil, whatever the life stage.
Bare shelves only a short-term hit to Coles and Woolies
18/01/2022  Empty shelves will negatively impact supermarkets in the second half of fiscal 2022 but the impact on long-term earnings is minimal, says Morningstar analyst Johannes Faul. 
Morningstar's outlook for 2022
17/01/2022  Bank earnings, house prices and China risk: Our experts and analysts discuss what they've got their eyes on in 2022.
Morningstar's Year in Review 2021
24/12/2021  Our experts and analysts weigh in on what mattered for investors last year.
"A bump in the road" as Magellan loses major client
21/12/2021  New products, lower fees and a portfolio of undervalued stocks set to help the fund manager right the ship. 
What role should Bitcoin play in your portfolio?
10/12/2021  And how does it match up against gold?
Years of demand remain for Australian coal producers
10/12/2021  Australian miners to be among the last standing as coal use fades.
Year-end portfolio rebalancing: What you need to know
08/12/2021  Rebalancing your portfolio is one of those beneficial habits that’s easy to let slide. But year-end is an ideal time to check how your portfolio is tracking against your target asset allocation. 
3 quality names from Stewart Investors
03/12/2021  The gold-rated fund manager shares three ideas with long-term potential.
Silver linings for investors amid the climate stalemate: COP26 debrief
01/12/2021  Long-term investor sees opportunities where businesses are moving towards a zero-carbon future faster than governments.
6 qualities of great index funds
30/11/2021  To understand your fund, get to know its underlying index.
Lazard's 3 top picks for the energy transition
29/11/2021  These companies are set to profit from the move to clean energy, says Lazard.
An uneven energy transition leaves room for coal and gas: COP26 debrief
24/11/2021  The results of the COP26 climate summit suggest coal demand is likely to persist for longer than expected.
What rising inflation means for Australian investors
17/11/2021  And how investors can protect their portfolios.
6 inflation-tough stocks for global investors
08/11/2021  Morningstar thinks these moaty companies will remain resilient in the face of inflation and ongoing supply chain challenges.
Risk/reward equation still looks good at Westpac
05/11/2021  Morningstar maintains fair value despite a fall in margins and slower progress on cost reductions.
These aren't the Bitcoin ETFs you're looking for
19/10/2021  These new US-listed exchange-traded funds will invest in bitcoin futures, not bitcoin itself.
ESG funds don't underperform - but nor do they outperform
15/10/2021  The ESG outperformance narrative is flawed, new research shows.
Building investment portfolios in a low interest rate environment
06/10/2021  Investors may need to hold more growth assets over the coming years, says Morningstar's Jody Fitzgerald.
Covid impacts still being felt in real estate and tech: Reporting season roundup
01/10/2021  And how G8 Education and Link Administration are positioned for long-term success.
Look to Credit Corp for a leading indicator of economic health: Reporting season roundup
30/09/2021  What Reporting Season August 2021 told investors about the health of the financials sector.
Cause for optimism at a2 Milk and Invocare: Reporting season roundup
28/09/2021  a2 milk is an opportunity to be greedy when others are fearful.
Post-covid normalisation is underway in healthcare: Reporting season roundup
23/09/2021  Covid's winners and losers are returning to their prior trajectories. 
One of the most underappreciated dangers of investing
21/09/2021  Sequence-of-returns risk matters for both retirees and savers. Here's why. 
REITs recover pandemic losses: Reporting season roundup
20/09/2021  Analysts expect the sector to recover to pre-Covid trading levels once borders reopen.
Australian banks face margin pressure amid low rates: Reporting season roundup
15/09/2021  Rising customer deposits and access to cheap funding helped Australia's banks stave off net interest margin pressure, but analysts see warning signs.
Greenwashing explained
14/09/2021  Morningstar's Hortense Bioy on how to spot greenwashing and how to avoid it.
Earnings down as private money circles infrastructure: Reporting season roundup
13/09/2021  Utilities and infrastructure names battle the impact of covid as private equity and pension funds circle. 
Frenzy of mergers in energy: Reporting season roundup
10/09/2021  Hydrocarbons poised for a comeback.
TPG tipped to recover as mobile competition eases: Reporting season roundup
09/09/2021  Providers have lifted prices after years of a debilitating chase for subscribers at all costs , says Morningstar's Brian Han.
Short-sellers bet against ARK Innovation ETF
08/09/2021  What shorting ETFs means for long-term investors.
Surging lumber prices were no match for Brambles: Reporting season roundup
07/09/2021  Morningstar senior analyst Grant Slade says Brambles secular growth trend is intact despite nearterm headwinds. He discusses results from the building and construction materials sector.
Miners soar thanks to iron ore: Reporting season roundup
03/09/2021  Miners bask in the glow of iron ore prices while bargains remain in coal.
BHP-Woodside merger is mutually beneficial
23/08/2021  Post-merger Woodside would be well positioned to deliver on the value we've seen for a long time, say Morningstar analysts.
Investors are getting serious about sustainability
16/08/2021  But the sector lacks uniformity, says Morningstar's Christopher Franz. 
Long term outlook for AGL is positive
11/08/2021  Higher wholesale electricity prices bode well for AGL, according to Morningstar senior equities analyst Adrian Atkins.
How you can hedge your portfolio against inflation
11/08/2021  Morningstar FundInvestor editor Russ Kinnel describes some direct and indirect hedges for inflation protection.
The iron ore party can't last: Morningstar
10/08/2021  Copper and iron ore have benefited materially from China’s stimulus and the developed world recovery. But Morningstar analyst Mat Hodge see these benefit as transitory.
What the Afterpay acquisition means for investors: Morningstar Minute
05/08/2021  We believe the transaction has a high chance of succeeding.
Cannabis' federal legal status is not a total buzzkill
03/08/2021  The industry still has significant growth potential.
Stock of the week: Toyota
03/08/2021  Is one of the biggest sponsors of the Olympics positioned for an all-electric future?
2 listed microcap names to consider
23/07/2021  Morningstar's Lex Hall talks micro-cap stock picks with Carlos Gil, chief investment officer at Microequities Asset Management.
Big returns, big risks: Making money with microcaps
22/07/2021  Mornngstar's Lex Hall catches up with Carlos Gil, chief investment officer at Microequities Asset Management.
3 small-caps with Dawn Kanelleas
21/07/2021  The head of Australian small and mid-cap stocks at First Sentier Investors has her eye on ARB, Breville and IDP Education.
Forecast 2021–2022: A correction could be around the corner
20/07/2021  The strong performances of global stock markets in 2020–21 are unlikely to be repeated in the coming year says Morningstar's Peter Warnes.
'Overvalued' warnings grow as ASX 200 hits new high
12/07/2021  Morningstar equity analysts warn that equities remain overvalued despite Australia's strong economic recovery.
What to know about private equity
08/07/2021  Private equity is an exciting area for investors, with lots of hotly-tipped stocks. But there are risks to be aware of, says Pitchbook analyst Dylan Cox.
Lazard's 3 top picks for the global covid recovery
08/07/2021  Warryn Robertson is looking at French infrastructure, retail pharmacy and tax services.
Aussie banks $34bn surplus points to more shareholder dividends, buybacks
06/07/2021  Australia's largest banks have excess capital because they cut dividends, were more conservative on lending, divested assets and raised equity last year. Morningstar's Nathan Zaia thinks most of it should be returned to shareholders.
Weighing up the PEXA IPO
02/07/2021  PEXA burst onto the ASX this week in the biggest float since 2019. Morningstar's Gareth James gives his take on the company's future growth prospects.
Can the iron ore price keep rising?
30/06/2021  Iron ore prices have  been on a tear, boosting the profits of Australia's top miners.  How did we get here and is the only way up? Lex Hall sits down with Morningstar's Mat Hodge.
2 new stocks to watch
28/06/2021  Morningstar has recently initiated coverage of a food delivery app and a consumer finance product. 
'Strongest earnings season I've ever seen'
24/06/2021  Meeting the deluge of demand is the biggest task for US companies, says Bell Asset Management's Ned Bell.
Biotech beyond covid
22/06/2021  Are there still opportunities in the biotech sector now the covid-19 vaccine roll out is underway? We ask International Biotechnology Trust manager Ailsa Craig
Alibaba is still deeply undervalued
21/06/2021  Morningstar's director of Asia equity research is confident the e-commerce giant will bounce back.
Weighing up the Endeavour IPO
18/06/2021  A wide moat and attractive dividend potential are among the key takeaways of Woolworth's decision to demerge from the liquor and hospitality group.
'Then we got hit with the equivalent of a war'
15/06/2021  Lazard Asset Management's Warryn Robertson explains how companies in the Global Equity Franchise fund have adjusted to covid, and assesses the threat of rising inflation.
Understanding Magellan's active ETF strategy
11/06/2021  Magellan's Craig Wright tells Emma Rapaport why it is leading the charge in the active ETF arena and how its global equity product works.
3 off-the-radar small caps
10/06/2021  Callum Burns of ICE Investors explains his conviction in pharmaceutical distributor Ebos, PSC Insurance Group, and elite sports analytics provider Catapult.
Small cap gems and how to find them
09/06/2021  Callum Burns explains how ICE Investors identifies companies with original products and sticky customer bases.
Stock of the Week: Salesforce.com
08/06/2021  They’re building an empire.
3 oil stocks we still like
07/06/2021  A year ago the oil price went negative. How have oil giants handled the past 12 months and what's the outlook from here? Morningstar analyst Allen Good explains.
Considering crypto? Here's what to think about
04/06/2021  As the investment world goes crazy for crypto, Morningstar Investment Management's Dan Kemp explains what to consider before putting it in your portfolio
Why we like Wizz Air
03/06/2021  The airline sector is set to recover as international travel resumes. Morningstar analysts think Wizz Air offer the best opportunity among low-cost carriers.
3 global infrastructure picks
28/05/2021  4D Infrastructure's Sarah Shaw outlines the investment case for Spanish multinationals Cellnex, and Iberdrola, and the potential of Mexican airports.
Are crypto ETFs coming?
28/05/2021  The SEC continues to sort out its regulatory concerns.
Stock of the Week: Apple
27/05/2021  We’re raising our fair value as sales hit new highs—but investors need to put it in perspective, says Andrew Willis.